Lisa Wilson | IR |
Scott Tarriff | CEO |
Brian Cahill | CFO |
David Pernock | President and COO |
Judith Ng-Cashin | Chief Medical Officer |
Randall Stanicky | RBC Capital Markets |
Tim Lugo | William Blair |
Brandon Folkes | Cantor Fitzgerald |
Good morning, everyone. My name is Leo. And I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review Call. All lines have been placed on mute to prevent any background noise.